A Dose Ranging Study of the Aeris Polymeric Lung Volume Reduction (PLVR) System in Patients With Advanced Upper Lobe Predominant Emphysema

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Advanced Emphysema
Interventions
DEVICE

Polymeric Lung Volume Reduction System (PLVR)

20ml (each) of polymer will be injected into 2, 3 or 4 subsegments during the first treatment. Eligible patients may have 20ml (each) of polymer will be injected into 2 or 3 subsegments during the second treatment.

Trial Locations (6)

Unknown

Chefarzt Klinik für Pneumologie, Bad Berka

Charité Universitätsmedizin Medizinische Klinik Infektiologie und Pulmologie, Berlin

Pneumologisches Forschungsinstitut, Großhansdorf

Thoraxklinik Heidelberg, Heidelberg

Lungenklinik Hemer, Hemer

Medizinische Klinik und Poliklinik Klinikum Großhadern, Munich

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Aeris Therapeutics

INDUSTRY

NCT00884962 - A Dose Ranging Study of the Aeris Polymeric Lung Volume Reduction (PLVR) System in Patients With Advanced Upper Lobe Predominant Emphysema | Biotech Hunter | Biotech Hunter